| Christopher James Ball, CRNA | |
|
701 Hewitt Blvd, Red Wing, MN 55066 | |
| (651) 267-5000 | |
| Not Available |
| Full Name | Christopher James Ball |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 19 Years |
| Location | 701 Hewitt Blvd, Red Wing, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467408625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R1557882 (Minnesota) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 1195 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System In Red Wing | Red wing, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164463659 PECOS PAC ID: 1951213487 Enrollment ID: O20031104000095 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
| Entity Name | Southdale Anesthesiologists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154381804 PECOS PAC ID: 6709842461 Enrollment ID: O20041203000743 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1538113022 PECOS PAC ID: 1951213487 Enrollment ID: O20070711000490 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1063435410 PECOS PAC ID: 4385556703 Enrollment ID: O20171011003946 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher James Ball, CRNA 200 1st St Sw, Rochester, MN 55905-0001 Ph: (651) 267-5000 | Christopher James Ball, CRNA 701 Hewitt Blvd, Red Wing, MN 55066 Ph: (651) 267-5000 |
News Archive
As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.
CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.
Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, reports a new study by researchers at Columbia University Medical Center.
A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.
Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.
› Verified 8 days ago
Betsy Ann Hundertmark, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 701 Fairview Blvd, Red Wing, MN 55066 Phone: 651-267-5000 | |
Justin Thomas Smith, APRN, CRNA, DNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000 | |
Carol C Nibbe, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 701 Fairview Blvd, Red Wing, MN 55066 Phone: 651-267-5000 | |
Linda M Buck, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000 | |
Matthew Jon Guse, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000 | |
Christopher William Saenz, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 561-267-5000 |